Navigation Links
NIH announces phase III clinical trial of creatine for Parkinson's disease

rl Kieburtz, M.D., M.P.H., of the University of Rochester in New York, and Barbara C. Tilley, Ph.D., of the Medical University of South Carolina in Charleston, and the patients will be seen by movement disorders specialists at the NET-PD sites across the United States and Canada.

PD is a degenerative disorder of the brain in which patients develop symptoms such as progressive tremor, slowness of movements, and stiffness of muscles. It affects at least one million people in the United States. Although certain drugs, such as levodopa, can reduce the symptoms of PD, there are no proven treatments that can slow the progressive deterioration in function.

Creatine is marketed as a nutritional supplement. Studies have suggested that it can improve the function of mitochondria, which produce energy inside cells. It also may act as an antioxidant that prevents damage from compounds that are harmful to cells in the brain. In a mouse model of PD, creatine is able to prevent loss of the cells that are typically affected.

"Creatine, or any compound that may slow the progression of PD, could have very important long-term benefits for people who are living with this disease," says John R. Marler, M.D., NINDS associate director for clinical trials.

The study will enroll people who have been diagnosed with PD within the past five years and who have been treated for two years or less with levodopa or other drugs that increase the levels of dopamine in the brain. Many of the symptoms of PD result from the loss of dopamine, a neurotransmitter that helps to control movement. Half of the participants will receive creatine and half will receive a placebo. Neither the participants nor their doctors will know which treatment they receive.

"We are studying a stage of the disease that usually hasn't been included in clinical studies," notes Dr. Kieburtz. The study is designed to include a broad range of people, with special efforts to
'"/>

Source:NIH/National Institute of Neurological Disorders and Stroke


Page: 1 2 3

Related biology news :

1. Wiley announces publication of Databasing the Brain
2. Nonlinear Dynamics announces more details of its global partnership with PerkinElmer
3. Neurologix announces positive results of gene therapy clinical trial in Parkinsons disease
4. Eisai announces Phase II data on E7389, a potential new therapy for the treatment of breast cancer
5. GlycoFi announces the first production of antibodies with human glycosylation in yeast
6. NHGRI announces new sequencing targets
7. CHAVI announces international search for genes affecting HIV response
8. NHGRI announces latest sequencing targets
9. MUHC announces a transplant first in Quebec
10. St. Jude announces breakthrough in eye cancer treatment
11. Worlds largest rainforest drying experiment completes first phase
Post Your Comments:
(Date:5/28/2015)... May 28, 2015 Industry analyst firm ... new report titled "Markets for Self-Healing Materials: 2015-2022." According ... capsule and vascular systems, biomaterials, relevant shape memory ... around $2.7 billion by 2020. The ... coverage of smart materials. Other recent n-tech reports have ...
(Date:5/22/2015)... , May 22, 2015  NXT-ID, Inc. (NASDAQ: NXTD ... it will be ending its promotional pricing and making the ... Laurence Savin , Head of Marketing said, "We,ve ... pricing until the end of May. To get your wocket ... when we open the store on June 1, you,ll receive ...
(Date:5/20/2015)... , May 20, 2015 /PRNewswire/ ... http://www.researchandmarkets.com/research/h8t4x6/5year ) has announced the addition ... the Global Iris Recognition Market"  report ... , ,This research service analyses trends ... the government and commercial sectors, globally. ...
Breaking Biology News(10 mins):The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 2The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 3NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2
... filaments. But their assembly is crucial for long-term potentiation (LTP), ... lay down memories. In the July 13, 2009 issue of ... Rex et al. reveal that LTP,s actin reorganization occurs in ... that helps explain why it is easy to encode new ...
... become just another fixture, it,s time to take a fresh ... to develop paper-based biosensors that can detect certain harmful toxins ... agents. In a paper published in the July issue ... team at McMaster University, working with the Sentinel Bioactive Paper ...
... , -- Results from Parascript SignatureXpert confirm that signatures ... Court of Moscow to initiate forensic examination and expert ... , BOULDER, Colo., June 22 Parascript, ... today announced that it has partnered with the Moscow ...
Cached Biology News:Building memories with actin 2Toxin detection as close as an inkjet printer 2Parascript Signature Verification Technology Used by Moscow Law Firm to Detect Signature Fraud in $160,000 Debt Collection Case 2Parascript Signature Verification Technology Used by Moscow Law Firm to Detect Signature Fraud in $160,000 Debt Collection Case 3
(Date:6/1/2015)... 2015  Albany Molecular Research Inc. (NASDAQ: ... has signed a collaborative agreement with biotechnology ... drug discovery services to global pharmaceutical and ... agreement, AMRI gains access to HarkerBIO,s uniquely ... customers will be able to access and ...
(Date:6/1/2015)... DUBLIN , May 29, 2015 ... the addition of the "2015 Strategies in ... their offering. This report presents a ... including: - Major issues pertaining to the ... economic, regulatory, demographic, social and technological trends with ...
(Date:6/1/2015)... 2015 Considerable experience to ... Creabilis Ltd, the dermatology company with ... for chronic pruritus (itch), announces today that it ... Board of Directors. Catherine brings wide ... financial strategy, allowing companies to continue their strong ...
(Date:5/31/2015)... Grow Med University (GMU) is a free, self-directed ... their own pace and dip into the rich treasure ... scientific and other informative articles, to hone their skills ... yet! , The medical marijuana industry is growing ... the U.S. and a slew of other businesses are ...
Breaking Biology Technology:AMRI and HarkerBIO Ink Collaborative Agreement in Buffalo, N.Y. 2AMRI and HarkerBIO Ink Collaborative Agreement in Buffalo, N.Y. 3Strategies in the UK Flow Cytometry Market 2015 2Creabilis Appoints Catherine Moukheibir as Chairman of its Board of Directors 2Creabilis Appoints Catherine Moukheibir as Chairman of its Board of Directors 3Grow Med University: a Brand New Online Hydroponics Course 2
... 5, 2011 Myriant Corporation today announced the ... targeted bio-based chemicals, including succinic acid and both ... cellulosic feedstocks. (Logo: http://photos.prnewswire.com/prnh/20110531/NE11071LOGO) ... our ability to continue driving the advancement and ...
... ZyGEM Corp. Ltd., a developer and marketer of innovative ... acids, today announced publication of an application note showing ... extract DNA from small samples of human hair.  The ... and reproducible DNA profiles for forensic casework analysis.  ZyGEM,s ...
... Joseph,s Hospital and Medical Center and the University of Arizona ... create the Valley Fever Center based at the hospital.  The ... more than 30 years of experience in treating and researching ... in Tucson in 1996. The center plans to ...
Cached Biology Technology:Myriant Produces Succinic Acid and Lactic Acid From Non-Food Cellulosic Feedstocks 2Application Note Shows ZyGEM's forensicGEM® Tissue Facilitates Forensic Casework by Rapidly and Reproducibly Extracting DNA From Human Hair 2Application Note Shows ZyGEM's forensicGEM® Tissue Facilitates Forensic Casework by Rapidly and Reproducibly Extracting DNA From Human Hair 3St. Joseph's Hospital, University of Arizona Create Valley Fever Center in Phoenix 2
... Product Goat polyclonal to Cholesterol ... Reactivity / Specificity Cross-reacts with ... Background Information Cholesterol oxidases exist ... oxidases and are implicated in bacterial pathogenesis. ...
Phospho-PERK (Thr980) Antibody...
Goat polyclonal to BACE1 ( Abpromise for all tested applications). entrezGeneID: 23621 SwissProtID: P56817...
Sheep polyclonal to Staphylococcus DNase ( Abpromise for all tested applications). Antigen: Full length native protein (purified)....
Biology Products: